Evidence map›Paper›PMID 25561709›Full record

ArticleInfection and immunity2015

The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA.

Claire Gendrin, Annalisa Lembo, Christopher Whidbey, Kellie Burnside, Jessica Berry, Lisa Ngo, Anirban Banerjee, Liang Xue, Justine Arrington, Kelly S Doran and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Claire GendrinDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA.
Annalisa LemboDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA.
Christopher WhidbeyDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA.
Kellie BurnsideDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA.
Jessica BerryDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA.
Lisa NgoDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA.
Anirban BanerjeeDepartment of Biology and Center for Microbial Sciences, San Diego State University, San Diego, California, USA.
Liang XueDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, USA.
Justine ArringtonDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, USA.
Kelly S DoranDepartment of Biology and Center for Microbial Sciences, San Diego State University, San Diego, California, USA.
W Andy TaoDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, USA.
Lakshmi RajagopalDepartment of Pediatric Infectious Diseases, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA lakshmi.rajagopal@seattlechildrens.org.
Seattle Children's Hospital · USPurdue University West Lafayette · USUniversity of Washington · USSan Diego State University · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
GBS mediated in utero fetal injuryR01AI100989 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2012 to 2016
$3.9M
Regulation of the physiologic and pathologic activation of the NLRP3-inflammasomeR01AI088255 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2010 to 2020
$3.9M
Blood-brain barrier in bacterial meningitisR01NS051247 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORAN, KELLY S · 2006 to 2015
$3.2M
Role of an ornithine rhamnolipid pigment in GBS virulenceR01AI112619 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2018
$2.4M
Indiana Clinical and Translational Sciences InstituteTL1TR001107 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$2.0M
New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling PathwaysR01GM088317 · NIGMS · PURDUE UNIVERSITY · PI TAO, W. ANDY · 2010 to 2014
$1.6M
Environmental Signals that regulate GBS virulenceR21AI109222 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2015
$553k
Eukaryotic-signaling mediates two-component regulation of GBS virulenceR56AI070749 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2013 to 2013
$482k
NCATS NIH HHS TL1 TR001107NCATS NIH HHS UL1 TR001108NIAID NIH HHS R01 AI088255NIAID NIH HHS R01AI088255NIAID NIH HHS R01 AI100989NIAID NIH HHS R01AI100989NIAID NIH HHS R01 AI112619NIAID NIH HHS R21 AI109222NIAID NIH HHS R21AI109222NIAID NIH HHS R56 AI070749NIAID NIH HHS T32 AI007509NIAID NIH HHS T32 AI07509NIGMS NIH HHS R01 GM088317NIGMS NIH HHS R01GM088317NINDS NIH HHS R01 NS051247NINDS NIH HHS R01NS051247
6 · The paper itself

Abstract

Group B streptococci (GBS; Streptococcus agalactiae) are beta-hemolytic, Gram-positive bacteria that are common asymptomatic colonizers of healthy adults. However, these opportunistic bacteria also cause invasive infections in human newborns and in certain adult populations. To adapt to the various environments encountered during its disease cycle, GBS encodes a number of two-component signaling systems. Previous studies have indicated that the TCS comprising the sensor histidine kinase RgfC and the response regulator RgfA mediate GBS binding to extracellular matrix components, such as fibrinogen. However, in certain GBS clinical isolates, a point mutation in rgfA results in premature truncation of the response regulator. The truncated RgfA protein lacks the C-terminal DNA binding domain necessary for promoter binding and gene regulation. Here, we show that deletion of rgfC in GBS strains lacking a functional RgfA increased systemic infection. Furthermore, infection with the rgfC mutant increased induction of proinflammatory signaling pathways in vivo. Phosphoproteomic analysis revealed that 19 phosphopeptides corresponding to 12 proteins were differentially phosphorylated at aspartate, cysteine, serine, threonine, or tyrosine residues in the rgfC mutant. This included aspartate phosphorylation of a tyrosine kinase, CpsD, and a transcriptional regulator. Consistent with this observation, microarray analysis of the rgfC mutant indicated that >200 genes showed altered expression compared to the isogenic wild-type strain and included transcriptional regulators, transporters, and genes previously associated with GBS pathogenesis. Our observations suggest that in the absence of RgfA, nonspecific RgfC signaling affects the expression of virulence factors and GBS pathogenesis.

Indexed as

Gene Expression Regulation, BacterialAmino Acid SequenceAnimalsBacterial ProteinsBrainCell LineEndothelial CellsGene Expression ProfilingHistidine KinaseHumansMaleMiceMice, Inbred StrainsMolecular Sequence DataMutationPhosphorylationBacterial ProteinsHistidine KinaseProtein Kinases

Identifiers

PMID25561709
PMCPMC4333453
OpenAlexW2166308543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.